Advances against aspergillosis.
نویسندگان
چکیده
William J. Steinbach, David A. Stevens, David W. Denning, and Richard B. Moss Division of Pediatric Infectious Diseases, Department of Pediatrics, and Duke University Mycology Research Unit, Duke University, Durham, North Carolina; Division of Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, and California Institute for Medical Research, San Jose, and Division of Infectious Diseases and Geographic Medicine, Department of Medicine, and Division of Pediatric Pulmonology, Stanford University Medical School, Stanford, California; School of Medicine, University of Manchester, Hope Hospital, Salford, and Wythenshawe Hospital, Manchester, United Kingdom
منابع مشابه
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
Major progress for the management of invasive aspergillosis has come from the introduction of new antifungals since the late 1990s. Although mortality of invasive aspergillosis remains as high as 30-50%. Backbone of management are prophylaxis, early diagnosis and early initiation of antifungals for reduction of invasive aspergillosis related mortality. Randomized trials have been undertaken for...
متن کاملInvasive aspergillosis: current and future challenges in diagnosis and therapy.
Invasive aspergillosis is an increasingly common disease. While there have been significant advances in the past decade, significant challenges remain in terms of diagnosis and therapy. Some of the recent advances are outlined and future opportunities to improve the unacceptable mortality that is currently associated with this infection are considered.
متن کاملCluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
management of cryptococcal disease. Clin Infect Dis 2000; 30: 710–8. 3. Sable CA, Strohmaier KM, Chodakewitz JA. Advances in antifungal therapy. Annu Rev Med 2008; 59: 455–73. 4. Baddley JW, Pappas PG. Antifungal combination therapy. Drugs 2005; 65: 1461–80. 5. Sionov E, Mendlovic S, Segal E. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experim...
متن کاملNewer combination antifungal therapies for invasive aspergillosis.
Optimal therapy for invasive aspergillosis is unknown, and many clinicians have attempted to utilize a combination antifungal approach to improve outcomes. However, while numerous in vitro studies, animal models, and clinical reports suggest the possibility that combination antifungal therapy might offer improved results, there is no definitive accepted strategy. The currently available antifun...
متن کاملAspergillosis Author : Doctor Jorge
Key-words Disease name and included diseases Definition Clinical presentation of the diseases Risk factors for Aspergillosis infections Diagnosis Epidemiology Treatment Surgical treatment References Abstract Aspergillosis is a large spectrum of fungal diseases, which primarily affect the lungs and are caused by members of the genus Aspergillus. A. fumigatus seems to be the most frequent species...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
دوره 37 Suppl 3 شماره
صفحات -
تاریخ انتشار 2003